These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Ridgefield Acquisition Corp.
|
|
(Exact name of registrant as specified in its Charter)
|
|
Nevada
|
84-0922701
|
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
|
incorporation or organization)
|
Identification Number)
|
|
225 N.E. Mizner Boulevard, Suite 400 Boca Raton, Florida 33432
|
|
(Address of Principal Executive Office) (Zip Code)
|
|
(561) 362-5385
|
|
(Registrant's telephone number including area code)
|
|
Large accelerated filer
|
¨
|
Accelerated filer
|
¨
|
|
Non-accelerated filer
|
¨
|
Smaller reporting company
|
x
|
|
Page
|
|||||
|
PART I
|
FINANCIAL INFORMATION
|
3
|
|||
|
Item 1.
|
Financial Statements
|
3
|
|||
|
Consolidated Balance Sheets as of June 30, 2011 (unaudited) and December 31, 2010
|
3
|
||||
|
Consolidated Statements of Operations and Comprehensive Income (Loss) for the Three Months and Six Months Ended June 30, 2011 and 2010 (unaudited)
|
4
|
||||
|
Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2011 and 2010(unaudited)
|
5
|
||||
|
Notes to Condensed Consolidated Financial Statements
|
6
|
||||
| Item 2. |
Management Discussion and Analysis of Financial Condition and Results of Operations
|
8
|
|||
|
Item 4.
|
Controls and Procedures
|
10
|
|||
|
PART II
|
OTHER INFORMATION
|
11
|
|||
|
Item 1.
|
Legal Proceedings
|
11
|
|||
|
Item 5.
|
Other Information
|
11
|
|||
|
Item 6.
|
Exhibits
|
11
|
|||
|
SIGNATURES
|
13
|
||||
|
June 30,
|
December 31,
|
|||||||
|
2011
|
2010
|
|||||||
|
(Unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS
|
||||||||
|
Cash and cash equivalents
|
$ | 73,025 | $ | 889,887 | ||||
|
TOTAL ASSETS
|
$ | 73,025 | $ | 889,887 | ||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 8,374 | $ | 946 | ||||
|
Accrued income tax
|
— | 13,411 | ||||||
|
TOTAL CURRENT LIABILITIES
|
8,374 | 14,357 | ||||||
|
STOCKHOLDERS' EQUITY
|
||||||||
|
Preferred stock, $.01 par value; authorized - 5,000,000 shares, Issued - none
|
— | — | ||||||
|
Common stock, $.001 par value; authorized - 30,000,000 shares, Issued and outstanding - 1,260,773 shares
|
1,261 | 1,261 | ||||||
|
Capital in excess of par value
|
2,272,883 | 2,272,883 | ||||||
|
Accumulated deficit
|
(2,209,493 | ) | (1,398,614 | ) | ||||
|
TOTAL STOCKHOLDERS' EQUITY
|
64,651 | 875,530 | ||||||
|
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY
|
$ | 73,025 | $ | 889,887 | ||||
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||
|
General and administrative expenses
|
$ | 30,654 | $ | 8,240 | $ | 42,879 | $ | 21,274 | ||||||||
|
TOTAL EXPENSES
|
30,654 | 8,240 | 42,879 | 21,274 | ||||||||||||
|
OTHER INCOME
|
||||||||||||||||
|
Interest Income
|
357 | 673 | 1,408 | 817 | ||||||||||||
|
Realized gain on investments
|
— | 25,734 | — | 272,134 | ||||||||||||
|
TOTAL OTHER INCOME
|
357 | 26,407 | 1,408 | 272,951 | ||||||||||||
|
NET INCOME (LOSS) BEFORE TAXES
|
(30,297 | ) | 18,167 | (41,471 | ) | 251,677 | ||||||||||
|
INCOME TAXES
|
(12,944 | ) | — | (12,944 | ) | — | ||||||||||
|
NET INCOME (LOSS)
|
$ | (43,241 | ) | $ | 18,167 | $ | (54,415 | ) | $ | 251,677 | ||||||
|
OTHER COMPREHENSIVE INCOME/(LOSS)
|
||||||||||||||||
|
Reclassification adjustment for gains included in net income
|
— | (13,412 | ) | — | (239,548 | ) | ||||||||||
|
OTHER COMPREHENSIVE INCOME/(LOSS)
|
— | (13,412 | ) | — | (239,548 | ) | ||||||||||
|
COMPREHENSIVE INCOME
|
$ | — | $ | 4,755 | $ | — | $ | 12,129 | ||||||||
|
NET INCOME PER COMMON SHARE
|
||||||||||||||||
|
Basic and Dilutive
|
$ | (.03 | ) | $ | .01 | $ | (.04 | ) | $ | .20 | ||||||
|
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING
|
||||||||||||||||
|
Basic and Dilutive
|
1,260,773 | 1,260,773 | 1,260,773 | 1,260,773 | ||||||||||||
|
Six Months Ended
|
||||||||
|
June 30
|
June 30,
|
|||||||
|
2011
|
2010
|
|||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
||||||||
|
Net income (loss)
|
$ | (54,415 | ) | $ | 251,677 | |||
|
Adjustment to reconcile net income (loss) to net cash used in operating activities
|
||||||||
|
Stock issued for professional services
|
— | 9,000 | ||||||
|
Realized gain on sales of investments
|
— | (272,134 | ) | |||||
|
Changes in assets and liabilities
|
||||||||
|
Increase (decrease) accounts payable and accrued expenses
|
(5,983 | ) | (9,201 | ) | ||||
|
Net Cash Used in Operating Activities
|
(60,398 | ) | (20,658 | ) | ||||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
||||||||
|
Proceeds from sale of investments
|
— | 608,902 | ||||||
|
Net Cash Provided by Investing Activities
|
— | 608,902 | ||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||
|
Payment for distribution of dividends
|
(756,464 | ) | — | |||||
|
Net Cash used in Financing Activities
|
(756,464 | ) | 608,902 | |||||
|
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
(816,862 | ) | 588,244 | |||||
|
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIODS
|
889,887 | 307,409 | ||||||
|
CASH AND CASH EQUIVALENTS, END OF PERIODS
|
$ | 73,025 | $ | 895,653 | ||||
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
3.1
|
Articles of Incorporation, incorporated by reference to Registration Statement No. 33-13074-D as Exhibit 3.1.
|
|
3.2
|
Amended Bylaws adopted June 1, 1987, incorporated by reference to Annual Report on Form 10-K for the fiscal year ended December 31, 1987 as Exhibit 3.2.
|
|
3.4
|
Articles of Amendment to Restated Articles of Incorporation dated March 7,1991. Incorporated by reference to Annual Report on Form 10-K for fiscal year ended December 31, 1990 as Exhibit 3.4.
|
|
3.5
|
Articles of Amendment to Restated Articles of Incorporation dated March 17, 1999, incorporated by reference to the Company's Current Report on Form 8-K reporting an event of March 9, 1999.
|
|
3.6
|
Articles of Incorporation of Bio-Medical Automation, Inc. a Nevada corporation, the Company's wholly owned subsidiary.
|
|
3.7
|
By-laws of Bio-Medical Automation, Inc. a Nevada corporation, the Company's wholly owned subsidiary.
|
|
10.1
|
OEM Purchase Agreement dated January 15, 1990, between the Company and Ariel Electronics, Inc. incorporated by reference to Annual Report on Form 10-K for the fiscal year ended December 31, 1989 as Exhibit 10.1.
|
|
10.2
|
Form of Convertible Promissory Note, 12/30/93 Private Placement incorporated by reference to Annual Report on Form 10-KSB for the fiscal year ended December 31, 1993 as Exhibit 10.2.
|
|
10.3
|
Form of Non-Convertible Promissory Note, 12/30/93 Private Placement incorporated by reference to Annual Report on Form 10-KSB for the fiscal year ended December 31, 1993 as Exhibit 10.3.
|
|
10.4
|
Form of Note Purchaser Warrant Agreement and Warrant, 12/30/93 Private Placement incorporated by reference to Annual Report on Form 10-KSB for the fiscal year ended December 31, 1993 as Exhibit 10.4.
|
|
10.5
|
Form of Promissory Note, April 1, 1996.
|
|
10.6
|
Form of Security Agreement, April 1, 1996.
|
|
10.7
|
Form of Common Stock Purchase Warrant, April 1, 1996.
|
|
10.8
|
Form of Promissory Note, July 1, 1996.
|
|
10.9
|
Form of April 1, 1996 Promissory Note Extension, October 17, 1996.
|
|
10.10
|
Form of Common Stock Purchase Warrant, October 10, 1996.
|
|
10.11
|
Asset Purchase Agreement with JOT incorporated by reference to Form 8-K reporting an event of November 4, 1998, and amendment thereto incorporated by reference to Form 8-K reporting an event of December 15, 1998.
|
|
10.12
|
Stock Purchase Agreement, between Bio-Medical Automation, Inc. and Steven N. Bronson, incorporated by reference to the Current Report on Form 8-K filed on April 6, 2000.
|
|
10.13
|
Employment Agreement between Bio-Medical Automation, Inc. and Steven N. Bronson, dated as of March 24, 2001, incorporated by reference to Quarterly Report on Form 10-QSB for the quarter ended March 31, 2001.
|
|
10.14
|
Mergers and Acquisitions Advisory Agreement, dated as of November 13, 2001, between Bio-Medical Automation, Inc. and Catalyst Financial LLC incorporated by reference to the Annual Report on Form 10-KSB for the year ended December 31, 2001.
|
|
10.15
|
Mergers and Acquisitions Advisory Agreement, dated as of April 1, 2005, between Ridgefield Acquisition Corp. and Catalyst Financial LLC.
|
|
10.16
|
Appointment of Atlas Stock Transfer Agent Corporation as the transfer Agent for Ridgefield Acquisition Corp.
|
|
10.17
|
Employment Agreement between Ridgefield Acquisition Corp. and Steven N. Bronson, dated as of March 28, 2006.
|
|
10.18
|
Addendum, dated as of February 1, 2006, to Mergers and Acquisitions Advisory Agreement, dated as of April 1, 2005, between Ridgefield Acquisition Corp. and Catalyst Financial LLC.
|
|
14
|
Code of Ethics
|
|
31*
|
President's Written Certification Of Financial Statements Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
32*
|
President's Written Certification Of Financial Statements Pursuant to 18 U.S.C. Statute 1350.
|
|
RIDGEFIELD ACQUSITION CORP.
|
|
|
By:
|
/s/ Steven N. Bronson
|
|
Steven N. Bronson, President
|
|
|
(Principle Executive Officer),
|
|
|
as Registrant's duly authorized
|
|
|
officer
|
|
Exhibit
|
||
|
Number
|
Description of Document
|
|
|
31
|
President's Statement Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32
|
President's Written Certification Of Financial Statements Pursuant to 18 U.S.C. Statute 1350.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|